BLUWU Blue Water Acquisition Corporation

On April 12, 2022, the Board of Directors of Clarus Therapeutics Holdings, Inc. (“Clarus”) established that the 2022 Annual Meeting of Stockholders of Clarus will be held on Tuesday, June 7, 2022. The record date for the determination of Clarus stockholders entitled to receive notice of and to vote at the 2022 Annual Meeting will be the close of business on Tuesday, April 12, 2022. Because the date of the 2022 Annual Meeting differs by more than thirty (30) days from the anniversary date of the 2021 Special Meeting in lieu of an Annual Meeting of Stockholders, which was held on August 27, 2021, the deadlines for any stockholder proposals pursuant to Rule 14a-8 under the Securities Exchange Act of 1934, as amended (the “Exchange Act”) and for any stockholder nomination or proposal outside of Rule 14a-8, as listed in the definitive proxy statement/prospectus, as filed with the Securities and Exchange Commission (the “SEC”) on July 23, 2021, are no longer applicable. Pursuant to Clarus’ bylaws (the “Bylaws”) and Rule 14a-5(f) of the Exchange Act, Clarus is hereby providing notice of the revised deadlines for such proposals via this Form 8-K.

To be considered for inclusion in this year’s proxy materials for the 2022 Annual Meeting, stockholder proposals must be submitted in writing by April 22, 2022, to Clarus’ Corporate Secretary at 555 Skokie Boulevard, Suite 340, Northbrook, Illinois, 60062. In addition to complying with this deadline, stockholder proposals intended to be considered for inclusion in Clarus’ proxy materials for the 2022 Annual Meeting must also comply with the Bylaws and all applicable rules and regulations promulgated by the SEC under the Exchange Act. Additionally, any stockholder who intends to submit a proposal regarding a director nomination or who intends to submit a proposal regarding any other matter of business at the 2022 Annual Meeting not to be included in Clarus’ proxy materials for the 2022 Annual Meeting, must also ensure that notice of any such nomination or proposal (including any additional information specified in the Bylaws) is received by the Corporate Secretary at Clarus’ principal executive offices on or before the close of business on April 22, 2022.